[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336883-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336883-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","intermediate-filaments-in-breast-cancer-progression-and-potential-biomarker-for-cancer-therapy-narrative-review","Intermediate Filaments in Breast Cancer Progression, and Potential Biomarker for Cancer Therapy - Narrative Review","","Intermediate filaments are cytoskeletal components, alongside actin and microtubules, composed of structurally related proteins with cell-type specific expression patterns. Altered expression of intermediate filaments is repeatedly linked to cancer progression, particularly the epithelial-to-mesenchymal transition (EMT) that increases migration and invasion. This narrative review examines cytoplasmic intermediate filaments—vimentin, nestin, and multiple cytokeratins—as prognostic or diagnostic biomarkers in breast cancer, and evaluates their potential as therapeutic targets for drug development.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/intermediate-filaments-in-breast-cancer-progression-and-potential-biomarker-for-cancer-therapy-narrative-review/336883/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/intermediate-filaments-in-breast-cancer-progression-and-potential-biomarker-for-cancer-therapy-narrative-review/336883.png","ImageObject",300,407,{"name":42,"@type":43},"River Wang","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role do intermediate filaments play in cancer progression, especially in breast cancer?","Question",{"text":63,"@type":64},"Intermediate filaments show altered expression patterns during cancer progression. This is closely tied to EMT, which supports increased cellular migration and invasion, contributing to metastasis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which intermediate filaments are emphasized as biomarkers or therapeutic targets?",{"text":68,"@type":64},"The review focuses on cytoplasmic intermediate filaments, specifically vimentin, nestin, and cytokeratins (including CK5/CK6, CK7, CK8/CK18, CK17, CK19, CK20, and CSK1).",{"name":70,"@type":61,"acceptedAnswer":71},"How is EMT connected to the cytoskeleton and metastatic behavior?",{"text":72,"@type":64},"EMT involves biochemical modifications initiated by transcription factors, including changes in cell-surface proteins, cytoskeletal rearrangement, ECM degradation through enzyme secretion, and microRNA expression alterations. These changes enhance mobility and enable migration and invasion.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336883,1790193895,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":108,"preview_page_count":33,"preview_urls":145},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Breast Cancer: Targets and Therapy Dovepress  \n Open Access Full Text Article REVIEW  \nIntermediate Filaments in Breast Cancer Progression, and Potential Biomarker for Cancer Therapy: A Narrative Review  \nWidad Aghnia Shalannandia 1 , Yoan Chou 2 , Muhammad Hasan Bashari 1 , 3 , Astrid Feinisa Khairani 1 , 3  \n1Graduate School of Master Program in Biomedical Sciences, Faculty of Medicine, Universitas Padjadjaran, Sumedang, Jatinangor, West Java, Indonesia; 2Graduate School of Master Program in Anti Aging and Aesthetic Medicine, Faculty of Medicine, Universitas Padjadjaran, Sumedang, Jatinangor, West Java, Indonesia; 3Department of Biomedical Sciences, Faculty of Medicine, Universitas Padjadjaran, Sumedang, Jatinangor, West Java, Indonesia  \nCorrespondence: Astrid Feinisa Khairani, Department of Biomedical Sciences, Faculty of Medicine, Universitas Padjadjaran, Jalan Raya Bandung – Sumedang Km 21, Jatinangor, Sumedang, West Java, 45363, Indonesia, Tel +62-22-7795594, Email [astrid.khairani@unpad.ac.id](astrid.khairani@unpad.ac.id)  \nAbstract: Intermediate filaments are one of the three components of the cytoskeletons, along with actin and microtubules. The intermediate filaments consist of extensive variations of structurally related proteins with specific expression patterns in cell types. The expression pattern alteration of intermediate filaments is frequently correlated with cancer progression, specifically with the epithelialto-mesenchymal transition process closely related to increasing cellular migration and invasion. This review will discuss the involvement of cytoplasmic intermediate filaments, specifically vimentin, nestin, and cytokeratin (CK5/CK6, CK7, CK8/CK18, CK17, CK19, CK20, CSK1), in breast cancer progression and as prognostic or diagnostic biomarkers. The potential for drug development targeting intermediate filaments in cancer will be reviewed.  \nKeywords: breast malignancy, cytokeratin, EMT, intermediate filament, keratin, nestin, vimentin  \nIntroduction  \nDuring tumor progression, the mutated cells undergo malignant transformation that induces a sequence of structural rearrangements. This cellular transformation is closely related to the Epithelial-to-Mesenchymal Transition (EMT) process that allows the cells to gain mobility and leads to the ability of the cells to migrate and invade the blood vessel, leading to cancer metastasis at a distant site. Multiple biochemical modifications happen to epithelial cells that undergo the EMT process to gain mobility and extracellular matrix (ECM) component productibility of mesenchymal cells. The biochemical mechanism includes initiation of EMT by transcription factors, expression of specific cell-surface proteins, cytoskeletal modification and rearrangement, enzyme secretion for ECM degradation, and alteration in specific microRNA expression. Thus, it leads to cancer progression and metastasis to distant sites.1–5  \nThe cytoskeleton’s intermediate filament plays a prominent role in maintaining cell integrity. The rearrangement of intermediate filaments, including vimentin, nestin, and keratins, has also been reported to be involved in cancer malignancy.6 Over the years, various intermediate filaments have been used in scientific and clinical studies as biomarkers to assist in identifying tumor types and prognoses and determining appropriate cancer treatment.7–9 The exploration of intermediate filaments has been studied in various cancers, including breast cancer. This cancer is ranked second after lung cancer for the mortality-to-incidence rate, which accounts for 15% .10 Breast cancer holds the first place globally as the highest cancer incidence in both sexes (11.7%) . While in the female population, the incidence rate of breast cancer reaches 24.5%, with a mortality rate of 15.5% .11  \nReceived: 3 August 2024  \nAccepted: 7 October 2024  \nPublished: 14 October 2024  \nBreast Cancer: Targets and Therapy 2024:16 689–704 689  \n© 2024 Shalannandia et al. This work is p","cbCaivVddf4C4Yx4","https://ap.wps.com/l/cbCaivVddf4C4Yx4","pdf",3592522,16,"English","# Introduction\n## Intermediate filaments in cancer studies\n### Types and structural characteristics","[{\"question\":\"What role do intermediate filaments play in cancer progression, especially in breast cancer?\",\"answer\":\"Intermediate filaments show altered expression patterns during cancer progression. This is closely tied to EMT, which supports increased cellular migration and invasion, contributing to metastasis.\"},{\"question\":\"Which intermediate filaments are emphasized as biomarkers or therapeutic targets?\",\"answer\":\"The review focuses on cytoplasmic intermediate filaments, specifically vimentin, nestin, and cytokeratins (including CK5/CK6, CK7, CK8/CK18, CK17, CK19, CK20, and CSK1).\"},{\"question\":\"How is EMT connected to the cytoskeleton and metastatic behavior?\",\"answer\":\"EMT involves biochemical modifications initiated by transcription factors, including changes in cell-surface proteins, cytoskeletal rearrangement, ECM degradation through enzyme secretion, and microRNA expression alterations. These changes enhance mobility and enable migration and invasion.\"}]","Intermediate Filaments in Breast Cancer Progression, and Potential Biomarker for Cancer Therapy - Narrative Review | PDF",1790016955,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/94e01e154d3465574688ebfe0159b75c.webp",983,1272,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9acdf86b7ecabe4d3805bbd2bb7465e9.webp",982,1270,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a303950d4dc6bacf13664d6808a186a1.webp",981,1269,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/809da957f1cb4b742ec07c266c5c163b.webp",980,1268]